Roche buys US Nimblegen for 272.5 mln usd |
|
|
|
Published
:
Tue, 19 Jun 2007 07:13
|
ZURICH (Thomson Financial) - Roche Holdings AG said it has agreed to acquire NimbleGen Systems -- a US based company active in high-density DNA microarrays -- for 272.5 mln usd.NimbleGen will become a fully integrated part of Roche Applied Science, part of the group's diagnostic division, the Swiss pharma group said.Roche said the deal allows it to enter the high-growth research microarrray market and to strengthen its presence in genomics research market.DNA microarrays are a widely used discovery and research tool in pharma research for the understanding of genetic causes of disease and predisposition factors, comparative genomic analysis and identification of potential drug targets.johanna.treeck@thomson.comjmt/jfrCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|
Print this Story
Roche sees competitive advantage in cancer drugs secure - head of pharma 